Lyra Therapeutics Inc. announced the appointment of Brad Smith to its Board of Directors. Mr. Smith is an experienced leader in the biotechnology and healthcare industry, with more than 27 years of experience primarily focused on finance and business development. Brad Smith has more than 27 years of experience leading business and financial operations for public and private companies in the biotechnology and healthcare industry. During his career, he has been instrumental in raising more than $800 million in private and public equity and debt financing, and has played a key role in business development and strategic planning functions, successfully guiding four companies through the initial public offering (IPO) process and growth stages of their businesses.